K Pharma,Inc. 4896Short Interest
No institution currently reports a short position of 0.5% or more in K Pharma,Inc. (4896). The last disclosure was on 2026-07-23 (GOLDMAN SACHS INTERNATIONAL, 0.48%).
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
82 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 6 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2025-04-24 |
|---|---|
| Latest disclosure | 2026-07-23 (GOLDMAN SACHS INTERNATIONAL, 0.48%) |
| Reporting institutions | 6 firms (82 reports) |
| Peak estimated short interest | 3.10% (2025-09-29, 3 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- UBS AG
- Morgan Stanley MUFG Securities Co., Ltd.
- GOLDMAN SACHS INTERNATIONAL
- Barclays Capital Securities Ltd
- JPM Securities Japan Co Ltd.
- Others
0.00%
Estimated short interest, 2026-11-18
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2026-03-26 | Morgan Stanley MUFG Securities Co., Ltd. | Position 57,400 shares | Ratio 0.49% | ▼0.06% | Below 0.5% |
| 2025-12-24 | UBS AG | Position 56,300 shares | Ratio 0.48% | ▼0.08% | Below 0.5% |
| 2025-05-19 | JPM Securities Japan Co Ltd. | Position 56,700 shares | Ratio 0.48% | ▼0.10% | Below 0.5% |
| 2026-07-23 | GOLDMAN SACHS INTERNATIONAL | Position 56,300 shares | Ratio 0.48% | ▼0.11% | Below 0.5% |
| 2025-11-11 | Barclays Capital Securities Ltd | Position 55,700 shares | Ratio 0.47% | ▼0.09% | Below 0.5% |
| 2025-09-30 | Nomura International plc | Position 23,200 shares | Ratio 0.19% | ▼0.40% | Below 0.5% |
Disclosure History 82 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-07-23 | GOLDMAN SACHS INTERNATIONAL | Position 56,300 shares | Ratio 0.48% | ▼0.11% | Below 0.5% |
| 2026-07-16 | GOLDMAN SACHS INTERNATIONAL | Position 69,600 shares | Ratio 0.59% | ▼0.10% | — |
| 2026-06-24 | GOLDMAN SACHS INTERNATIONAL | Position 80,900 shares | Ratio 0.69% | ▼0.06% | — |
| 2026-03-26 | Morgan Stanley MUFG Securities Co., Ltd. | Position 57,400 shares | Ratio 0.49% | ▼0.06% | Below 0.5% |
| 2026-03-25 | Morgan Stanley MUFG Securities Co., Ltd. | Position 64,200 shares | Ratio 0.55% | ▼0.08% | — |
| 2026-03-24 | Morgan Stanley MUFG Securities Co., Ltd. | Position 73,600 shares | Ratio 0.63% | ▲0.24% | — |
| 2026-02-25 | GOLDMAN SACHS INTERNATIONAL | Position 88,100 shares | Ratio 0.75% | ▲0.09% | — |
| 2026-02-20 | GOLDMAN SACHS INTERNATIONAL | Position 77,600 shares | Ratio 0.66% | ▲0.16% | — |
| 2026-01-29 | GOLDMAN SACHS INTERNATIONAL | Position 59,100 shares | Ratio 0.50% | ▲0.07% | — |
| 2025-12-24 | UBS AG | Position 56,300 shares | Ratio 0.48% | ▼0.08% | Below 0.5% |
| 2025-12-22 | UBS AG | Position 65,300 shares | Ratio 0.56% | ▼0.12% | — |
| 2025-12-16 | UBS AG | Position 79,800 shares | Ratio 0.68% | ▼0.11% | — |
| 2025-12-02 | UBS AG | Position 92,800 shares | Ratio 0.79% | ▼0.09% | — |
| 2025-11-26 | UBS AG | Position 102,600 shares | Ratio 0.88% | ▼0.11% | — |
| 2025-11-17 | UBS AG | Position 116,000 shares | Ratio 0.99% | ▼0.05% | — |
| 2025-11-12 | UBS AG | Position 120,700 shares | Ratio 1.04% | ▼0.14% | — |
| 2025-11-11 | Barclays Capital Securities Ltd | Position 55,700 shares | Ratio 0.47% | ▼0.09% | Below 0.5% |
| 2025-11-07 | Barclays Capital Securities Ltd | Position 65,900 shares | Ratio 0.56% | ▼0.06% | — |
| 2025-11-05 | UBS AG | Position 137,900 shares | Ratio 1.18% | ▼0.10% | — |
| 2025-10-28 | Barclays Capital Securities Ltd | Position 72,400 shares | Ratio 0.62% | ▲0.07% | — |
| 2025-10-27 | Barclays Capital Securities Ltd | Position 64,200 shares | Ratio 0.55% | ▼0.05% | — |
| 2025-10-24 | Barclays Capital Securities Ltd | Position 69,900 shares | Ratio 0.60% | ▲0.01% | — |
| 2025-10-21 | Barclays Capital Securities Ltd | Position 69,400 shares | Ratio 0.59% | ▼0.01% | — |
| 2025-10-20 | Barclays Capital Securities Ltd | Position 70,500 shares | Ratio 0.60% | ▲0.09% | — |
| 2025-10-16 | Barclays Capital Securities Ltd | Position 60,200 shares | Ratio 0.51% | ▲0.08% | — |
| 2025-10-09 | UBS AG | Position 148,800 shares | Ratio 1.28% | ▼0.11% | — |
| 2025-10-01 | UBS AG | Position 162,200 shares | Ratio 1.39% | ▼0.07% | — |
| 2025-10-01 | Morgan Stanley MUFG Securities Co., Ltd. | Position 54,700 shares | Ratio 0.47% | ▼0.12% | Below 0.5% |
| 2025-09-30 | Nomura International plc | Position 23,200 shares | Ratio 0.19% | ▼0.40% | Below 0.5% |
| 2025-09-30 | Morgan Stanley MUFG Securities Co., Ltd. | Position 68,700 shares | Ratio 0.59% | ▼0.46% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| Veritas In Silico Inc.130A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Chordia Therapeutics Inc.190A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| TAUNS Laboratories,Inc.197A | Standard Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Tsubota Laboratory Incorporated4890 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| TMS Co.,Ltd.4891 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Cyfuse Biomedical K.K.4892 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Noile-Immune Biotech Inc.4893 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Cuorips Inc.4894 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Innovacell Inc.504A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| J-Pharma Co.,Ltd.520A | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical |